This report titled 'Developments in the Japanese Healthcare Industry: Pharmaceuticals and Medical Devices' discusses recent developments within the Japanese healthcare industry, with a particular focus on the pharmaceuticals and medical devices markets. This report identifies a number of promising developments which collectively make this a very attractive market for EU companies, such as growing demand for pharmaceuticals and prescription drugs, several recent innovative breakthroughs particularly in the cancer drugs and therapeutic drugs markets, the presence of several world class pharmaceutical firms, and sustained efforts by the Japanese government to promote international collaborative research through various regional Japanese clusters. This report finds that Japanese demand for pharmaceuticals and medical devices is solid, and is likely to continue to grow due to recent government initiatives to stimulate growth in the Japanese economy.
Dr. Umemura is a lecturer in International Business and Japanese Studies at Cardiff Business School, her research interests are in biomedical innovation, the healthcare industry (pharmaceuticals, medical devices), and business history. She has written a book and a wide range of articles on the pharmaceutical industry in Japan. Click here to view her profile page.
What are the opportunities and risks to enter the growing market of telemedicine in Japan?The Japanese telemedicine market is anticipated to grow. The potential of telemedicine for the development of
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
Hundreds of web pages with up-to-date information on Japan, more than 400 market reports and recorded webinars available as well as a lot of detailed information on Japanese business culture.